M
Marie Jachiet
Researcher at University of Paris
Publications - 116
Citations - 1554
Marie Jachiet is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Dupilumab. The author has an hindex of 15, co-authored 79 publications receiving 1007 citations. Previous affiliations of Marie Jachiet include Paris Diderot University & Paris Descartes University.
Papers
More filters
Journal ArticleDOI
Vascular skin symptoms in COVID-19: a French observational study.
Jean-David Bouaziz,Tu Anh Duong,Marie Jachiet,C. Velter,P. Lestang,Charles Cassius,A. Arsouze,E Domergue Than Trong,Martine Bagot,Edouard Begon,Luc Sulimovic,Michel Rybojad +11 more
TL;DR: Coronavirus 19 (COVID‐19) was declared as a pandemic viral infection by the World Health organization on March 11th 2020 and angiotensin‐converting enzyme 2 (ACE2) is a cellular receptor for CO VID‐19.
Journal ArticleDOI
Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France.
Adèle de Masson,Jean-David Bouaziz,Luc Sulimovic,Charles Cassius,Marie Jachiet,Marius-Anton Ionescu,Michel Rybojad,Martine Bagot,Tu Anh Duong,Sndv +9 more
Journal ArticleDOI
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.
Sarah Faiz,Jonathan Giovannelli,Céline Podevin,Marie Jachiet,Jean-David Bouaziz,Ziad Reguiai,Audrey Nosbaum,Audrey Lasek,Marie-Christine Ferrier le Bouedec,Aurélie Du Thanh,Nadia Raison-Peyron,Florence Tetart,Anne-Bénédicte Duval-Modeste,Laurent Misery,François Aubin,Anne Dompmartin,C. Morice,Catherine Droitcourt,Angèle Soria,Jean-Philippe Arnault,J. Delaunay,Emmanuel Mahé,Marie-Aleth Richard,A. Schoeffler,Jean-Philippe Lacour,Edouard Begon,Amélie Walter-Lepage,Anne-Sophie Dillies,Sandrine Rappelle-Duruy,Stéphane Barete,N. Bellon,Nathalie Beneton,A. Valois,Sébastien Barbarot,Julien Sénéchal,Delphine Staumont-Sallé +35 more
TL;DR: This real-life study demonstrated a similar dupilumab effectiveness as that seen in clinical trials, but it also revealed a higher frequency of conjunctivitis and eosinophilia.
Journal ArticleDOI
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients.
Marie Jachiet,Béatrice Flageul,Alban Deroux,Alain Le Quellec,François Maurier,Florence Cordoliani,Pascal Godmer,C. Abasq,Leonardo Astudillo,P. Belenotti,Didier Bessis,Adrien Bigot,Marie-Sylvie Doutre,Mikael Ebbo,Isabelle Guichard,Eric Hachulla,Emmanuel Héron,Géraldine Jeudy,Noémie Jourde-Chiche,Denis Jullien,Christian Lavigne,Laurent Machet,Marie-Alice Macher,Clotilde Martel,Sara Melboucy-Belkhir,C. Morice,Antoine Petit,Bernard Simorre,Thierry Zenone,Laurence Bouillet,Martine Bagot,Véronique Frémeaux-Bacchi,Loïc Guillevin,Luc Mouthon,Nicolas Dupin,Selim Aractingi,Benjamin Terrier +36 more
TL;DR: The clinical spectrum and the therapeutic management of patients with HUV are analyzed to analyzed and it is shown that HUV is an uncommon vasculitis of unknown etiology that is rarely described in the literature.
Journal ArticleDOI
Anti‐IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss): Data on Seventeen Patients
Marie Jachiet,Maxime Samson,Vincent Cottin,Jean-Emmanuel Kahn,Guillaume Le Guenno,Philippe Bonniaud,Hervé Devilliers,Laurence Bouillet,Anne Gondouin,Fatma Makhlouf,Nadine Meaux-Ruault,H. Gil,Boris Bienvenu,André Coste,Matthieu Groh,Violaine Giraud,Stéphane Dominique,Bertrand Godeau,Xavier Puéchal,Chahéra Khouatra,Marc Ruivard,Claire Le Jeunne,Luc Mouthon,Loïc Guillevin,Benjamin Terrier +24 more
TL;DR: The efficacy and safety of omalizumab, an anti‐IgE monoclonal antibody, in patients with refractory and/or relapsing eosinophilic granulomatosis with polyangiitis (Churg‐Strauss) (EGPA).